Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05412 (
c-Jun
)
11,453
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Proteins with LIM domains have been implicated in transcriptional regulation. The four and half LIM domain (FHL) group of LIM-only proteins is composed of five members, some of which have been shown to have intrinsic activation function. Here we show that
FHL2
is the only member of the family whose expression is inducible upon serum stimulation in cultured cells. Induction of
FHL2
is coordinated in time with the increased levels of two early-response products, the oncoproteins Fos and Jun.
FHL2
associates with both Jun and Fos, in vitro and in vivo. The
FHL2
-Jun interaction requires the Ser-63-Ser-73 JNK phosphoacceptor sites in
c-Jun
, but not their phosphorylation.
FHL2
powerfully stimulates Fos- and Jun-dependent transcription, thereby acting as an inducible coactivator of AP-1 function. Moreover, we show that intracellular localization of
FHL2
is controlled by signaling events and a Crm1-dependent active nuclear export mechanism. Thus,
FHL2
, as an inducible coactivator of AP-1, coordinately participates with Fos and Jun in the early transcriptional response to serum factors.
...
PMID:The LIM-only protein FHL2 is a serum-inducible transcriptional coactivator of AP-1. 1264 11